Annual Reviews

Please follow the links to download our annual reviews as 
electronic image files. If you would prefer to have a hard copy instead,
 please contact us.
Annual review 2016

Annual review 2015

Annual review 2014

Annual review 2013

Annual review 2012

Annual review 2011

Annual review 2010

Annual review 2009

Annual review 2008

Annual review 2007

Available technologies

Licensing Cambridge innovation

Cambridge Enterprise works in collaboration with University of 
Cambridge researchers to market and license available technologies 
ranging from the biosciences to engineering.

We have completed more than 1,000 commercial agreements.

We welcome contact from companies interested in licensing available technologies from the University of Cambridge, and work with companies on an individual basis to identify specific areas of interest.

Image: The chromosome screening technology developed by University of Cambridge spin-out BlueGnome has shown to increase in vitro fertilisation (IVF) success rates by 65% over the current methods.

Commercialise your research

Inventions, ideas, know-how and licensing

Helping academics develop their ideas and inventions into 
opportunities that are attractive to business and investors is at the 
heart of Cambridge Enterprise and its Technology Transfer teams.

Our teams’ mission is to commercialise University knowledge and technology by working with academics, commercial partners, investors, the NHS and research funders to bring potentially big ideas to market, including by assisting with the formation of new companies and developing licensing opportunities.

We work with University colleagues through the entire commercialisation process, and often with those whose ideas are still in the very earliest stages of development. We’re here to help you commercialise your research.

Understanding your options

Cambridge Enterprise works to develop successful opportunities by helping academics apply for translational funding opportunities, undertaking market analysis, bringing together experts to scope and develop new technologies, finding development partners and investors, and negotiating and managing commercial deals through licensing IPR, including patents, know-how, data and copyright.

Whatever route your idea takes, the first thing you need to do is contact us to talk through the options. Your idea can be at any stage of development and in any form, such as:

  • a research topic that is relevant to industry needs
  • software
  • a design (for a circuit or object)
  • the creation of reagents or questionnaires
  • a new methodology
  • an algorithm
  • Patentable technologies

Disclosing your idea

Whether your idea is in its infancy or well-defined, we encourage you to fill out a disclosure form.

  • Cambridge Enterprise will handle your idea with strict confidence (please note that we will disclose the idea to your head of department if we add it to our portfolio).
  • We’re happy to talk, even if your idea is not fully formed – we can help you decide how to move forward.
  • If you choose to develop your idea independently of Cambridge Enterprise, we will work with you to give you the necessary rights from the University.

The process

  1. Once you’ve provided us with a completed disclosure form, we’ll meet with you to discuss your ideas and any commercial applications.
  2. We’ll review the competitive landscape – assessing the published papers and (if appropriate) patent applications that may be similar.
  3. We may contact some companies to establish whether your idea solves a relevant problem.
  4. Sometimes at this stage we may have a more detailed conversation with a company, which may require confidentiality agreements be put in place.
  5. These conversations may point to a need for more translational research before we engage with industry; we can help you find funding for that purpose.
  6. Occasionally we may decide that Cambridge Enterprise is not the best route for commercialisation in which case we would discuss alternative options with you.
  7. In cases where patent protection is appropriate, we’ll work with you and a patent agent to file a patent application – we will manage the patent prosecution but we will need your input at various stages.
  8. If no licensee has been identified, we’ll market your idea and try to find a good match. This could be through an existing company or we might help you start one of your own.
  9. Cambridge Enterprise will take assignment of any registerable rights (patent, trademark, registered designs) and a licence to any non-registerable rights (know-how, copyright, unregistered designs, database rights) so that we can act on your behalf and on behalf of the University in commercialisation of an idea.
  10. We negotiate with the licensee to agree terms for the commercialisation of your idea in return for a revenue share or other appropriate consideration.
  11. Revenue received by Cambridge Enterprise will be shared with you, your department and the University according to the University’s IP policy (for registerable rights).

Why license your work?

A licence is a legal agreement in which the owner of intellectual property grants specific rights to another party, to use, manufacture or sell the technology.

Our team finds potential commercialisation partners through extensive industry contacts, specialist databases, web searches and targeted marketing. You may already know of companies that may be interested in using your technology.

So why should you license your work?

  • A licence gives specific rights to the licensee in exchange for a fair return to the academics and University.
  • Cambridge Enterprise negotiates with licensees on a case-by-case basis, with the aim of supporting the business opportunity while getting a fair return for the inventors and the University.
  • University research is often a long way from what is needed in a commercial product and so agreeing on a value for the idea upfront is in practice impossible. An ongoing relationship through a licence allows both parties to share appropriately in any success.
  • Licences can be exclusive (granted just to one partner) or non-exclusive (granted to multiple partners), and limited to specific fields or territories, depending on what is best for that opportunity.
  • Cambridge Enterprise requires licensees to remain committed to the commercial development of the idea or to return their licence, preventing University research from being used simply to block the licensee’s competitors.

What can be licensed?

The most common types of IP rights are confidential information, copyright, patents, trademarks and design rights.

  • Copyright – the expression of ideas (e.g. software)
  • Database rights – collections of data (e.g. customer details)
  • Design rights – designs (e.g. the shape and appearance of a bottle or jar)
  • Knowledge – know-how (e.g. recipes can be a trade secret)
  • Research reagents and materials – (e.g. model organisms, proteins, DNA/RNA, etc)
  • Patents – how something works (e.g. the method of production)
  • Trademarks – the designation of origin, reputation of goods and services (e.g. logo)

Image: University spin-out Sphere Fluidics’ fusion biochip, which was licensed with the help of Cambridge Enterprise’s Technology Transfer teams.

Start a company

Do you want to start a University spin-out?

Whether you’re actively seeking investment money
 or are just considering the formation of a University spin-out, Seed 
Funds, the business creation and funding division of Cambridge 
Enterprise, can help.

With nearly 20 years of experience in company creation, our team 
has the proven know-how to support students and academics through direct
 investment as they build teams and raise the financing they need to 
develop products from their research. We create partnerships and link 
entrepreneurs with sources of angel and VC investing, as well as a 
network of mentors and management.

The support we provide

Cambridge Enterprise supports those trying to start a company based directly on University research or people, investing up to £۵۰۰,۰۰۰ in each University spin-out from investment funds we manage on the University’s behalf.

Significant follow-on funding is available through Cambridge Enterprise’s sister fund, Cambridge Innovation Capital (CIC). CIC has strong ties with the University of Cambridge and works closely with Cambridge Enterprise on its investments. CIC may also invest at the seed stage as a precursor to further investment.

We can work with you to make your business plan stronger, we can connect you with industry mentors and management, and we can fund consultants and proof of market studies. Since 1995, we have invested in 62 companies that together boast a three-year survival rate of 80%, compared with a national average of 30% for technology companies. You can review our equity portfolio.

If you are developing a business idea, use these slides to structure your thoughts into a business plan.

Read more

The investment we offer

We invest the University seed funds in new companies started by staff and students to enable the commercial development of University research. As such, we offer a range of investment to help develop new ventures. Among them are:

  • PathFinder investment, up to £۲۰,۰۰۰ to help carry out market and intellectual property assessments and business strategies.
  • Fast 50, a Cambridge Enterprise initiative that offers up to £۵۰,۰۰۰ for work on time-sensitive projects and critical experiments that need investment delivered quickly.
  • Seed investment, up to £۵۰۰,۰۰۰ in the initial round, to provide the first stages of company funding to advance technology development and management.

Once our investment is completed we continue to work with you to help develop and grow your business.

 The process

  • Contact us for an early discussion about your idea and its potential. A member of the Seed Funds team will work with you to develop your idea and guide you through the investment process.
  • If applicable, apply for PathFinder investment to develop your plans – we can make these smaller awards easily.
  • For larger investment, you will need to present your business plan to the Seed Funds team, which will make an assessment about whether to progress your application to the Cambridge Enterprise Investment Committee.
  • If successful, you will present your idea to our Investment Committee.

With Investment Committee approval we will put in place the necessary legal agreements to complete the investment.

Image: Dr Darrin M. Disley, Horizon Discovery Group Plc CEO and President, centre, celebrates at the London Stock Exchange.